Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021
The new report looks ahead to a post-pandemic 2021 with pharma manufacturing capacity and payment structures shifting as new sourcing
Catalent Signs Commercial Supply Agreement with Blueprint Medicines Following FDA Approval of GAVRETO™ (pralsetinib)
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies,
FIP expert group issues advice for pharmacists on COVID-19 tests
The Hague — To help pharmacists advise people on COVID-19 tests, the International Pharmaceutical Federation (FIP), has today issued a guidance
UCB taps Medisafe in development of digital companion to support patient engagement
Medisafe, a leading digital therapeutics company specializing in digital companions, has been selected by UCB to develop branded digital drug
CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event
CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December 2020), with a physical exhibition running alongside
Recommended Drugs to Undergo Incineration Process
Contributing factors such as the excessive carbon dioxide in the atmosphere and burned fossil fuels wounds the earth at large.